Low-molecular-weight Heparin for the Treatment of Acute Ischemic Stroke

Completed

Phase N/A Results

Summary of Purpose

To determine if low-molecular-weight heparin is more effective and safer than standard (unfractionated) heparin in treating acute ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 September 2005.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Chinese University of Hong Kong & Sanofi Recherche, Gentilly, France.

Trial Design

Randomized, double-blind, placebo-controlled trial.

Contacts

Not available